Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Kerui Donghe Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a key subsidiary of the Chongqing Kerui Pharmaceutical Group. The company specializes in the research, development, and large-scale production of chemical generic drugs and traditional Chinese medicine (TCM) formulations. Its diverse product portfolio addresses critical therapeutic areas, including cardiovascular health, respiratory conditions, and infectious diseases. Operating from modern facilities in Chongqing, the company adheres to strict national Good Manufacturing Practice (GMP) standards to ensure product quality and safety. Kerui Donghe serves as a vital component of the regional healthcare infrastructure, providing a wide range of essential medications to the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Kerui Donghe Pharmaceutical.